HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Attila Nagy Selected Research

Catheter Ablation

9/2020Uninterrupted Dabigatran Administration Provides Greater Inhibition against Intracardiac Activation of Hemostasis as Compared to Vitamin K Antagonists during Cryoballoon Catheter Ablation of Atrial Fibrillation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Attila Nagy Research Topics

Disease

33Neoplasms (Cancer)
04/2024 - 02/2002
10Carcinoma (Carcinomatosis)
12/2005 - 02/2002
8Prostatic Neoplasms (Prostate Cancer)
02/2006 - 02/2002
7Endometrial Neoplasms (Endometrial Cancer)
11/2005 - 09/2002
5Body Weight (Weight, Body)
02/2011 - 02/2002
5Ovarian Neoplasms (Ovarian Cancer)
03/2005 - 09/2002
4COVID-19
03/2024 - 01/2022
4Hypertension (High Blood Pressure)
12/2023 - 02/2011
4Chronic Obstructive Pulmonary Disease (COPD)
01/2023 - 08/2018
4Neoplasm Metastasis (Metastasis)
01/2022 - 04/2003
4Ischemic Stroke
01/2021 - 01/2017
4Breast Neoplasms (Breast Cancer)
12/2005 - 09/2003
3Inflammation (Inflammations)
12/2023 - 03/2015
3Colonic Neoplasms (Colon Cancer)
01/2022 - 02/2002
3Melanoma (Melanoma, Malignant)
06/2006 - 09/2004
3Pancreatitis
12/2004 - 03/2002
2Infections
03/2024 - 04/2002
2Cardiovascular Diseases (Cardiovascular Disease)
12/2023 - 01/2021
2Cystic Fibrosis (Mucoviscidosis)
11/2023 - 01/2019
2Lung Diseases (Lung Disease)
11/2023 - 01/2019
2Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 02/2002
2Metabolic Syndrome (Dysmetabolic Syndrome X)
06/2021 - 05/2018
2Intracranial Hemorrhages (Intracranial Hemorrhage)
11/2019 - 01/2017
2Stroke (Strokes)
11/2019 - 01/2013
2Insulin Resistance
05/2019 - 10/2017
2Necrosis
12/2016 - 03/2002
2Renal Cell Carcinoma (Grawitz Tumor)
11/2005 - 08/2005
2Pancreatic Neoplasms (Pancreatic Cancer)
10/2005 - 09/2004
2Lymphoma (Lymphomas)
09/2005 - 05/2005
2Glioblastoma (Glioblastoma Multiforme)
07/2005 - 09/2004
2Jaundice (Icterus)
12/2004 - 07/2004
2Brain Neoplasms (Brain Tumor)
09/2004 - 04/2003
2Lung Neoplasms (Lung Cancer)
09/2004 - 04/2003
2Small Cell Lung Carcinoma (Small Cell Lung Cancer)
09/2004 - 04/2003
1Periodontal Diseases (Periodontal Disease)
03/2024
1Pneumonia (Pneumonitis)
12/2023
1Residual Neoplasm
01/2023
1Cognitive Dysfunction
12/2022
1Community-Acquired Infections
11/2022
1Tuberculosis (Tuberculoses)
07/2022
1Pulmonary Tuberculosis
07/2022

Drug/Important Bio-Agent (IBA)

18AN 204 (AN 201)IBA
06/2006 - 02/2002
16Gonadotropin-Releasing Hormone (GnRH)FDA Link
02/2006 - 02/2002
13Doxorubicin (Adriamycin)FDA LinkGeneric
02/2006 - 02/2002
12Messenger RNA (mRNA)IBA
04/2023 - 02/2002
11Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
06/2006 - 02/2002
10Proteins (Proteins, Gene)FDA Link
12/2023 - 10/2002
10AN 238IBA
06/2006 - 02/2002
10LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
02/2006 - 02/2002
10BombesinIBA
01/2006 - 04/2003
9AN 207IBA
02/2006 - 02/2002
9AN 215IBA
01/2006 - 10/2003
9lysine(6)-doxorubicin LHRHIBA
11/2005 - 09/2002
7AndrogensIBA
05/2019 - 02/2002
6Somatostatin Receptors (Somatostatin Receptor)IBA
06/2006 - 02/2002
5Gastrin-Releasing PeptideIBA
01/2006 - 09/2004
4Biomarkers (Surrogate Marker)IBA
12/2023 - 04/2012
4Tissue Plasminogen Activator (Alteplase)FDA Link
01/2021 - 01/2017
4RC 121IBA
06/2006 - 02/2002
4RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
10/2005 - 02/2002
3LipidsIBA
04/2019 - 10/2017
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
12/2023 - 11/2022
2ivacaftorIBA
11/2023 - 01/2019
2Factor XIII (Coagulation Factor XIII)IBA
01/2021 - 01/2018
2Glucose (Dextrose)FDA LinkGeneric
05/2018 - 10/2017
2Membrane Transport Proteins (Biological Pump)IBA
11/2005 - 09/2005
2Peptide Receptors (Peptide Receptor)IBA
11/2005 - 09/2004
2Antineoplastic Agents (Antineoplastics)IBA
11/2005 - 10/2005
2LigandsIBA
10/2005 - 05/2003
2Triptorelin Pamoate (Trelstar)FDA Link
08/2005 - 10/2003
2BilirubinIBA
12/2004 - 07/2004
2Peptides (Polypeptides)IBA
09/2004 - 04/2003
2ErbB Receptors (EGF Receptor)IBA
10/2003 - 10/2002
2pentetreotide (OctreoScan)FDA Link
05/2003 - 04/2003
1Hypoglycemic Agents (Hypoglycemics)IBA
04/2024
1Anti-Bacterial Agents (Antibiotics)IBA
03/2024
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
12/2023
1lumacaftorIBA
11/2023
12019-nCoV Vaccine mRNA-1273IBA
04/2023
1BNT162 VaccineIBA
04/2023
1BIBP COVID-19 vaccineIBA
04/2023
1VaccinesIBA
04/2023
1Methotrexate (Mexate)FDA LinkGeneric
01/2023
1FluoridesIBA
12/2022
1Lisinopril (Prinivil)FDA LinkGeneric
11/2022
1EnalaprilFDA LinkGeneric
11/2022
1Isoniazid (Ftivazide)FDA LinkGeneric
07/2022
1Hyaluronic Acid (Hyaluronan)IBA
07/2022
1PowdersIBA
07/2022
1Mannose (D-Mannose)IBA
07/2022
1Dosage Forms (Dosage Form)IBA
07/2022

Therapy/Procedure

23Therapeutics
01/2023 - 02/2002
23Drug Therapy (Chemotherapy)
06/2006 - 02/2002
3Aftercare (After-Treatment)
05/2019 - 09/2002
3Injections
09/2003 - 02/2002
2Nebulizers and Vaporizers (Inhaler)
01/2023 - 07/2019
2Length of Stay
11/2022 - 02/2022
2Conservative Treatment
12/2016 - 02/2011
1Dental Care
03/2024
1Respiratory Therapy (Therapy, Respiratory)
01/2023